← Insider Monitor
Beyond Air, Inc. logo
XAIR

Beyond Air, Inc.

Nasdaq · Surgical & Medical Instruments & Apparatus

3
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Beyond Air develops nitric oxide generation and delivery systems for treating respiratory conditions, including a device that produces high-concentration nitric oxide gas for hospital use in treating pulmonary hypertension in newborns. The company is also researching nitric oxide-based therapies for viral and fungal lung infections and solid tumor treatment.

Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Garden City, NY
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Lin Yi-Chien10% OwnerBuy$43KOct 1, 2026
Lin Yi-Chien10% OwnerBuy$8KSep 29, 2026
Lin Yi-Chien10% OwnerBuy$5KSep 30, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for XAIR.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable XAIR activity by email

Free alerts for the insider and congressional trades worth watching.

Leave mobile blank for email only. Outside US/Canada, include + and your country code.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.